UA102705C2 - Пленкообразующий раствор на основе мочевины для лечения ногтевого псориаза - Google Patents

Пленкообразующий раствор на основе мочевины для лечения ногтевого псориаза

Info

Publication number
UA102705C2
UA102705C2 UAA201106327A UAA201106327A UA102705C2 UA 102705 C2 UA102705 C2 UA 102705C2 UA A201106327 A UAA201106327 A UA A201106327A UA A201106327 A UAA201106327 A UA A201106327A UA 102705 C2 UA102705 C2 UA 102705C2
Authority
UA
Ukraine
Prior art keywords
film
urea
forming solution
treatment
nail psoriasis
Prior art date
Application number
UAA201106327A
Other languages
English (en)
Ukrainian (uk)
Inventor
Софі Шесной
Марлен ДЕЛОНУА
Ела Кубетергес
Паскаль ЛЕФРАНСУА
Original Assignee
Пьєр Фабр Дермо-Косметік
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пьєр Фабр Дермо-Косметік filed Critical Пьєр Фабр Дермо-Косметік
Publication of UA102705C2 publication Critical patent/UA102705C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Изобретение относится к пленкообразующему раствору, который содержит: от 10 до 20 % мочевины, от 5 до 15 % пленкообразующего полимера, от 45 до 65 % полярного растворителя, от 1 до 20 % сорастворителя, от 0,01 до 5 %, пластификатора, выбранного из группы, которая состоит из диэтилфталата, триэтилцитрата, дибутилсебацината, диэтилсебацината, дибутилфталата, ацетилтриэтилцитрата и полиэтиленгликолов, и воду до 100 %, предназначенного для лечения ногтевых грибковых инфекций и ногтевого псориаза.
UAA201106327A 2008-10-21 2009-10-21 Пленкообразующий раствор на основе мочевины для лечения ногтевого псориаза UA102705C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857146A FR2937250B1 (fr) 2008-10-21 2008-10-21 Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
PCT/EP2009/063771 WO2010046375A1 (en) 2008-10-21 2009-10-21 Urea-based film-forming solution for treating nail psoriasis

Publications (1)

Publication Number Publication Date
UA102705C2 true UA102705C2 (ru) 2013-08-12

Family

ID=40823172

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201106327A UA102705C2 (ru) 2008-10-21 2009-10-21 Пленкообразующий раствор на основе мочевины для лечения ногтевого псориаза

Country Status (24)

Country Link
US (1) US20110200544A1 (ru)
EP (1) EP2349243B1 (ru)
JP (1) JP2012506372A (ru)
KR (1) KR20110071118A (ru)
CN (1) CN102186468B (ru)
AR (1) AR074048A1 (ru)
AU (1) AU2009306462B2 (ru)
BR (1) BRPI0919833A2 (ru)
CA (1) CA2740001A1 (ru)
ES (1) ES2560178T3 (ru)
FR (1) FR2937250B1 (ru)
GE (1) GEP20135746B (ru)
HK (1) HK1156532A1 (ru)
IL (1) IL212372A0 (ru)
MA (1) MA32800B1 (ru)
MX (1) MX2011004016A (ru)
NZ (1) NZ592733A (ru)
PL (1) PL2349243T3 (ru)
PT (1) PT2349243E (ru)
RU (1) RU2508090C2 (ru)
TN (1) TN2011000167A1 (ru)
UA (1) UA102705C2 (ru)
WO (1) WO2010046375A1 (ru)
ZA (1) ZA201103437B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
WO2014159930A1 (en) * 2013-03-14 2014-10-02 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
CN104758273B (zh) * 2015-04-09 2018-04-20 山东罗欣药业集团股份有限公司 一种尿素微囊制剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
ATE320250T1 (de) * 2000-01-03 2006-04-15 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
AU2002248308B2 (en) * 2001-01-09 2006-12-07 Israel Dvoretzky Therapeutic film forming composition and treatment system
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6821508B2 (en) * 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
DK1423101T3 (da) * 2001-09-04 2011-05-23 Trommsdorff Arzneimittel Anvendelse af et plaster til behandlingen af onychomycosis
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
CA2492976C (en) * 2002-09-05 2011-11-01 Galderma Research & Development, S.N.C. Solution for ungual and peri-ungual application
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
WO2005011565A2 (fr) * 2003-07-29 2005-02-10 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff

Also Published As

Publication number Publication date
KR20110071118A (ko) 2011-06-28
AU2009306462B2 (en) 2013-08-22
PL2349243T3 (pl) 2016-07-29
GEP20135746B (en) 2013-02-11
IL212372A0 (en) 2011-06-30
RU2508090C2 (ru) 2014-02-27
AU2009306462A1 (en) 2010-04-29
CA2740001A1 (en) 2010-04-29
EP2349243B1 (en) 2015-11-11
PT2349243E (pt) 2016-03-14
WO2010046375A1 (en) 2010-04-29
BRPI0919833A2 (pt) 2015-12-15
AR074048A1 (es) 2010-12-22
CN102186468A (zh) 2011-09-14
JP2012506372A (ja) 2012-03-15
US20110200544A1 (en) 2011-08-18
EP2349243A1 (en) 2011-08-03
FR2937250A1 (fr) 2010-04-23
TN2011000167A1 (en) 2012-12-17
ES2560178T3 (es) 2016-02-17
HK1156532A1 (en) 2012-06-15
FR2937250B1 (fr) 2013-05-10
RU2011119924A (ru) 2012-11-27
MA32800B1 (fr) 2011-11-01
CN102186468B (zh) 2014-02-12
NZ592733A (en) 2012-03-30
ZA201103437B (en) 2012-01-25
MX2011004016A (es) 2011-05-19

Similar Documents

Publication Publication Date Title
AU2018256579A1 (en) Methods for preparing a skin graft
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
AU2017382297A8 (en) Phosphodiesterase inhibitors and methods of microbial treatment
CY1118655T1 (el) Χρηση 2,4-πυριμιδινοδιαμινων για τη θεραπεια της αθηροσκληρωσης
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
RS53236B (en) BETA-AMYLOIDOSIS PEPTIDES
WO2016113550A3 (en) Dressing
CA3010582A1 (en) Extracellular vesicles for agent delivery
MX2018003961A (es) Carboxamidas aciladas de n-(1,2,5-oxadiazol-3-il)-,n-(1,3,4-oxadia zol-2-il)-, n-(tetrazol-5-il)- y n-(triazol-5-il)-arilo, y sus usos como herbicidas.
DE602004011243D1 (de) Gleitüberzug für medizinprodukt
WO2014160906A3 (en) Urethane based polymeric extenders for compositions to modify the surface properties of substrates
WO2017091739A8 (en) Topical film-forming spray
NZ607306A (en) Compounds and methods for skin repair
EP4241844A3 (en) Compositions for topical treatment of microbial infections
WO2015143295A3 (en) Hydrogel toxin-absorbing or binding nanoparticles
TR201818825T4 (tr) Kardi̇yak hi̇pertrofi̇ni̇n tedavi̇si̇ne ve tanisina yöneli̇k lncrnalar
MX2018007854A (es) Recubrimientos lubricantes con grupos salinos superficiales.
BR112017023722A2 (pt) composição formadora de película curável, substrato revestido e método para revestir um substrato
PH12019500083A1 (en) Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
MX2021001087A (es) Equipos industriales para el tratamiento de frutas y verduras.
EP4011936A4 (en) POLYMER CONTAINING FLUOROPOLYETHER GROUP, SURFACE TREATMENT AGENT AND ARTICLE
UA102705C2 (ru) Пленкообразующий раствор на основе мочевины для лечения ногтевого псориаза
WO2010134827A9 (en) Extended acting oxygen generating composition for treating microbial infections
IN2015KN00212A (ru)
UA110325C2 (en) Medicinal carbohydrates for treating respiratory conditions